Intelligent Bio Solutions Announces Fiscal Q3 2025 Financial Results and Key Operational Achievements

20% sequential quarterly revenue growth and 91% year-over-year quarterly gross profit growth

Continued momentum from recurring higher-margin cartridge sales now reaching 58% of total sales for the nine months ended March 31, 2025 

Read more at globenewswire.com